(Q38003501)
Statements
1 reference
The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease (English)
1 reference
Apostolos Kontzias
1 reference
Petros Efthimiou
1 reference
17 April 2012
1 reference
1 reference
42
1 reference
2
1 reference
201-205
1 reference
Identifiers
1 reference
1 reference